CLINICAL EVALUATION OF UTTHAMANI KUDINEER FOR ACUTE NASOPHARYNGITIS IN CHILDREN

CLINICAL EVALUATION OF UTTHAMANI KUDINEER FOR NEERKANA MAANTHAM (ACUTE NASOPHARYNGITIS) IN CHILDREN

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/06/025820

Enrollment

Registered

2020-06-11

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00- Acute nasopharyngitis [common cold]

Interventions

Intervention1: UTTHAMANI KUDINEER: 5-10 ml (1-2years) 10-15 ml(2-3years) will be given orally twice a day for a period of 7 days Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Patient having any three of the clinical symptoms must be present, Cough, Running nose, Fever, Malaise, Diarrhea, Loss of appetite,

Exclusion criteria

Exclusion criteria: Children below 1 year and above 3 years age. Bronchial asthma, Bronchitis Continuous fever for more than 5 days Signs of dehydration

Design outcomes

Primary

Measure	Time frame
It is mainly assessed by comparing the reduction in clinical symptoms before and after treatmentTimepoint: 1 YEAR	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactDr M Meenakshi Sundaram

National Institute of Siddha

dramalaaruldhas@gmail.com9940429202

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026